5 studies found for:    TC-5619
Show Display Options
Rank Status Study
1 Completed TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia
Conditions: Cognitive Dysfunction;   Schizophrenia
Interventions: Drug: TC-5619;   Drug: Placebo
2 Completed Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: TC-5619-238 5mg;   Drug: TC-5619-238 25mg;   Drug: Placebo
3 Completed Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TC-5619;   Drug: Placebo
4 Completed Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
Conditions: Schizophrenia;   Negative Symptoms;   Cognitive Dysfunction
Interventions: Drug: TC-5619;   Drug: Placebo
5 Completed Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Condition: ADHD
Interventions: Drug: TC-5619-238;   Drug: Placebo

Indicates status has not been verified in more than two years